In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. 

Having started her career in pharma before the market access function existed, Jie is an industry veteran. We cover the changes she's seen over the last 24 years, including multi-stakeholder capitalisation - what it means to Jie and why she feels it's important for market access leaders.

The opinions shared in this podcast are Jie's own views.

Send us a text